01 7Onoact
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 42
2019 Revenue in Millions : 46
Growth (%) : -10
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 42
2020 Revenue in Millions : 40
Growth (%) : 14
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 35
2021 Revenue in Millions : 42
Growth (%) : -16
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 29
2022 Revenue in Millions : 35
Growth (%) : -7
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 57
2016 Revenue in Millions : 53
Growth (%) : 7
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 41
2017 Revenue in Millions : 53
Growth (%) : -22%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 46
2018 Revenue in Millions : 43
Growth (%) : 7
LOOKING FOR A SUPPLIER?
